Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-03

Clinical Trial Update: Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing lornoxicam to placebo for acute treatment of migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lornoxicam (lornoxicam)

Snippet

Sponsor: POZEN | Conditions: Headache (Migraine) | Phase 2 | Status: COMPLETED